LGC Clinical Diagnostics Demonstrates Lab Solutions and Processes to Enhance QC Efficiencies
By LabMedica International staff writers Posted on 25 May 2023 |

LGC Clinical Diagnostics (Middlesex, UK) is participating in the 2023 WordLab-EuroMedLab Congress where the company’s quality control experts are demonstrating how automated processes with Multichem independent QC and IAMQC QC data management software can enhance QC efficiencies in the laboratory.
LGC’s brands include three IVD manufacturers of QMTs (Maine Standards Company, SeraCare and Technopath Clinical Diagnostics) and one manufacturer of viral and bacterial antigens and antibodies (The Native Antigen Company). At EuroMedLab 2023, LGC is showcasing various product offerings, including Multichem Independent Quality Control, VALIDATE calibration and verification materials, as well as its leading serology portfolio – ACCURUN, alongside its Clinical Genomics portfolio including Seraseq for NGS.
Technopath’s Multichem Independent Quality Control materials have a broader analyte range, enabling extensive consolidation of the test menu. This results in simplified lab inventory, cost reduction, and increased efficiencies. Its flagship products, Multichem IA Plus and Multichem S Plus, combine to offer over 190 tests. These can replace up to 8 rival products, streamlining lab operations. IAMQC Software, designed to support the Multichem QC product line, offers a suite of QC software tools for lab managers and technologists, allowing real-time QC results analysis. It helps automate, centralize, standardize, and enhance QC processes in labs. Its modules can be customized to cater to the different QC needs of individual labs.
The VALIDATE range of calibration and verification materials from Maine Standards Company are user-friendly kits that help document linearity, calibration verification, and linear range verification, as needed by several inspection bodies. They also aid in troubleshooting instrument systems, reagent issues, and calibration inconsistencies. They are available in a variety of product configurations, specifically formulated to maximize reportable ranges with minimum dilutions.
SeraCare's ACCURUN controls and reference materials are developed to be weakly reactive, providing additional confidence in lab test results. SeraCare’s Seraseq Next-generation sequencing (NGS) reference materials aid in building, validating, implementing, and standardizing superior clinical genomics assays. Its customizable biological materials help diagnostic assay developers build more robust assays swiftly. SeraCare's readily accessible antibodies and immunoassay reagents can accelerate research and IVD assay development.
Related Links:
LGC
Latest EUROMEDLAB 2023 News
- DIESSE Diagnostica Unveils CHORUS EVO Immunochemistry Analyzer
- LumiraDx Demonstrates Fast, High Performance, Portable POC Diagnostic Solution
- Thermo Fisher Presents Latest Solutions in Laboratory Equipment and Technology
- Beckman Coulter Unveils New DxI 9000 Access Immunoassay Analyzer
- STAGO sthemO and sthemE Product Ranges Make World Premiere
- Sansure Biotech Demonstrates iPonatic III Portable Molecular Workstation
- Greiner Bio-One Presents Complete Concept of Digitalized Sample Collection Process
- BioPerfectus Showcases SAW-48 Automated Nucleic Acid Workstation
- Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution
- Werfen Showcases Latest Innovations in Specialized Diagnostics
- Binding Site Showcases Optilite System for Special Protein Testing
- Sebia Presents Innovative Solutions for Screening and Diagnostics
- DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics
- Abbott Introduces GLP Systems Track Laboratory Automation Solution
- Randox Presents Future of Diagnostic Technology
- QuidelOrtho Highlights Innovative Point-of-Care Diagnostic Solutions
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreHematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg)
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read morePathology
view channel
Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more.jpg)
Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more